Dr Sarah Knaggs


Research Administrator

School of Dentistry

Contact details

Telephone +44 (0)121 237 2926

Fax +44 (0)121 237 2882

Email s.knaggs@bham.ac.uk

The School of Dentistry
College of Medical and Dental Sciences
University of Birmingham
St Chad's Queensway
B4 6NN
United Kingdom


Sarah is Research Administrator to the School of Dentistry and provides support to staff on all matters relating to postgraduate research student administration and research.


  • Certificate in Social Sciences, Open University, 2003
  • PhD in Medicinal Chemistry, Cardiff University, 1999
  • BSc (Hons) in Biomolecular and Biomedical Chemistry, University of Wales Swansea, 1996


Following a PhD in medicinal chemistry, Sarah undertook postdoctoral research at Cardiff University, the University of Reading and Wake Forest University, USA. She has also worked as a medical writer for an international medical communications agency. Prior to joining the University of Birmingham in 2010, Sarah worked as a Research Facilitator at the University of Oxford Department for Continuing Education for more than three years. In this role she provided strategic input into the development of research within the Department, and comprehensive support for research, public engagement and knowledge transfer funding applications. Sarah also supported the CPD division on new business initiatives and curriculum development projects. 


  • Poole, L.B., Klomsiri, C., Knaggs, S.A., Furdui, C.M., Nelson, K.J., Thomas, M.J., Fetrow, J.S., Daniel, L.W., King, S.B. (2007), Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins, Bioconjugate Chemistry, 18:2004-2017.
  • Poole, L.B., Zeng, B.B., Knaggs, S.A., Yakubu, M., King, S.B., (2005), Synthesis of chemical probes to map sulfenic acid modifications on proteins, Bioconjugate Chemistry, 16:1624-1628.
  • Knaggs, S., Malkin, H., Osborn, H.M.I, Williams, N.A.O, Yaqoob, P. (2005), New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT), Organic & Biomolecular Chemistry, 3:4002-4010.
  • McGuigan, C., Harris, S.A., Daluge, S.M., Gudmundsson, K.S., McLean, E.W., Burnette, T.C., et al. (2005), Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency, Journal of Medicinal Chemistry, 48: 3504-3515.
  • Harris, S.A., McGuigan, C., Andrei, G., Snoeck, R., De Clercq, E., Balzarini, J. (2001), Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)2 '-deoxyuridine, Antiviral Chemistry & Chemotherapy, 12: 293-300.
  • Knaggs, M.H., McGuigan, C., Harris, S.A., Heshmati, P., Cahard, D., Gilbert, I.H., Balzarini, J. (2000), A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T, Bioorganic & Medicinal Chemistry Letters, 10: 2075-2078.
  • McGuigan, C., Slater, M.J., Parry, N.R., Perry, A., Harris, S. (2000), Synthesis and antiviral activity of acyclovir-5 '-(phenyl methoxy alaninyl) phosphate as a possible membrane-soluble nucleotide prodrug, Bioorganic & Medicinal Chemistry Letters, 10: 645-647.

Back to top